Stocks / NASDAQ / Nabriva Therapeutics AG

Nabriva Therapeutics AG

Our Opinion

Nabriva Therapeutics AG is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“Substantial lung penetration, as demonstrated by epithelial lining fluid and macrophage concentrations, in animal and human studies.” (Page 14) Read the following document

Company Description

Nabriva Therapeutics AG is a clinical-stage biopharmaceutical company. It engages in the research and development of novel antibiotics to treat infections, with a focus on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. [Source: MarketWatch]

Company Website: http://www.nabriva.com